Reistone Biopharma Company Limited
Clinical trials sponsored by Reistone Biopharma Company Limited, explained in plain language.
-
New pill aims to cut dangerous COPD attacks in half
Disease control Recruiting nowThis study tests an experimental tablet called RSS0343 in people with chronic obstructive pulmonary disease (COPD). The goal is to see if the drug can reduce the number of moderate or severe flare-ups over 48 weeks. About 237 adults aged 40 to 80 with COPD will take either the ta…
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New drug RSS0343 tested in healthy people for safety first
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new drug called RSS0343 in 48 healthy adults aged 18 to 55. Participants take the drug or a placebo by mouth, and researchers monitor side effects and how the drug moves through the body. The goal is to gather safety and dosing informa…
Phase: PHASE1 • Sponsor: Reistone Biopharma Company Limited • Aim: Knowledge-focused
Last updated May 26, 2026 06:11 UTC